Form D · Biotechnology

QUANTALIFE INC

Pleasanton, CA · CIK 0001441786

Offering snapshot reported Jul 21, 2011 · SEC filing

Reported sold
$3.56M
Indefinite offering
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 8, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 21, 2011Initial$3,557,182No comparison21SEC filing
Dec 17, 2010Amendment$17,165,298$9,665,298vs Jun 21, 201018SEC filing
Jun 21, 2010Initial$7,500,000No comparison5SEC filing
Jun 2, 2009Initial$7,955,437No comparisonNot reportedSEC filing
Jul 31, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-163270

Source: Form D, filed Jul 21, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher T Blisard Director
Isaac Bright Executive
Bill W. Colston Director, Executive
William W Colston Director, Executive
Paul A. Conley Director
Richard Ding Director
Benjamin J. Hindson Executive
Paul K. Kidman Executive
Michael Y. Lucero Executive
Fred P. Milanovich Director
Michael J. Moniz Director
Kevin Ness Executive
Peter Christian Olivo Executive
Serge Saxonov Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
7068 Koll Center Parkway Suite 401
Pleasanton, CA, 94566